How Cancer Vaccine Tech Shaped COVID Response
Elie Dolgin • February 2, 2021
The record-breaking speed of vaccine development in response to the coronavirus outbreak relied in part on manufacturing infrastructure, technology development, and research tools previously built for oncologic products.
Continue reading at Cancer Discovery.
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.